Catalyze Preclinical Services Program

Catalyze Preclinical Services Program Catalyze preclinical services support preclinical development activities from end stage proof of concept, through preclinical development and us regulatory approval. applicants request specific services to advance their technology. Facilitates the transition of basic science discoveries into viable diagnostic and therapeutic candidates cleared for human testing. offers heart, lung, blood and sleep investigators funding, technical services, training, and mentorship.

Catalyze Preclinical Services Program The catalyze preclinical services program focuses on services not typically part of r33 activities in the companion catalyze product definition awards. the catalyze preclinical services program supports activities after end stage proof of concept through preclinical development and us regulatory approval. Catalyze preclinical services support preclinical development activities from end stage proof of concept, through preclinical development and us regulatory approval. applicants request specific services to advance their technology. All applicants for catalyze regulatory must submit an expression of interest form (eoi). if your project is in scope, it will be assigned for scientific and business review, and you may be invited to complete an application. The catalyze preclinical services program supports activities for technology development of products that are at end stage proof of concept through preclinical development and us regulatory approval.

Catalyze Preclinical Services Program All applicants for catalyze regulatory must submit an expression of interest form (eoi). if your project is in scope, it will be assigned for scientific and business review, and you may be invited to complete an application. The catalyze preclinical services program supports activities for technology development of products that are at end stage proof of concept through preclinical development and us regulatory approval. In this presentation, dr. pieck will explain what the program seeks to accomplish in providing preclinical services, along with details of the application process. The catalyze preclinical services program supports activities for technology development of products that are at end stage proof of concept through preclinical development and us regulatory approval. Applicants can request a range of preclinical services including preclinical efficacy studies, dose range finding studies (i.e., early toxicology studies), glp toxicology studies, or in vivo animal studies for devices. applicants can also request services for manufacturing. The catalyze coordinating center (rti) will select cros cmos that will provide preclinical services. additional commercialization milestones will be required of the investigator.